# Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment

> **NCT06235697** · PHASE3 · RECRUITING · sponsor: **Canadian Cancer Trials Group** · enrollment: 710 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** Radiation
- **RADIATION:** Radiation SBRT only
- **DRUG:** ADT

## Key facts

- **NCT ID:** NCT06235697
- **Lead sponsor:** Canadian Cancer Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-25
- **Primary completion:** 2032-10-31
- **Final completion:** 2033-04-30
- **Target enrollment:** 710 (ESTIMATED)
- **Last updated:** 2026-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06235697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06235697, "Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06235697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*